
COVIDã¯ã¯ãã³ã«ããè² å·è ãç¶åºããäžãå¿ããŠã¯ãªããªãããšâŠå»åŠã¯ç±³åœã«ãããäž»èŠãªæ»å ã§ãã
å èšäºã¯ãã¡ã/Original article here
2021幎以éã«èŠ³æž¬ãããå šæ»å æ»äº¡çã®æ¥äžæã¯ãç±³åœé£åå»è¬åå±ã«ããèŽæ»æ§ã¯ã¯ãã³COVID-19ã®æå¹åãšé¢ä¿ãããã®ã ãããïŒ
å²åŠè ã§ããç¥åŠè ã§ãããã€ã¯ã³ã»ã€ãªããã¯ã1974幎ã«çºè¡šãããå»åŠã®å®¿åœããšããå ±èãšä»éããè«æã§ãå»çå°éå®¶ã®è¡çºãšé¢é£ããå¥åº·æ¿çãããç£æ¥ãšå®æã®äž¡æ¹ããšããŠãå¥åº·ã«å¯Ÿãã倧ããªè åšããšãªã£ãŠãããšå€§èã«ã䞻匵ããã
å»åŠéèªã®ç·šéè ãšããŠé·å¹ŽæŽ»èºããäžæ£ãªå¥åº·èª¿æ»ãæ¹å€ããŠãããªãã£ãŒãã»ã¹ãã¹ãªã©ã®äž»èŠãªå»åŠè ã¯ãåŸã«ã€ãªããã®ãç°ææ§ãïŒå»åž«ãè¬ã蚺æè¬ãç é¢ããã®ä»ã®å»çæ©é¢ã...ãç æ°ãåŒãèµ·ããèŠå ããšããŠåãç æ°ã«å¯Ÿããé èªïŒã«é¢ããå èŠæ§ã«ãé©ãã¹ããä¿¡é Œã眮ããŠããã
1999幎ã«ã¯ãã§ã«ãInstitute of MedicineïŒå»åŠç ç©¶æïŒããå»çé誀ããç·æ¥ãã€åºç¯ãªå ¬å ±åé¡ã®ãããã©ã³ã¯ãã«äœçœ®ã¥ããŠããã
2000幎ã«ã¯ããžã§ã³ãºã»ãããã³ã¹ã®å ¬è¡è¡çå°éå®¶ããŒãã©ã»ã¹ã¿ãŒãã£ãŒã«ãå士ããããå ·äœçã«ãå»åç ã¯ã¢ã¡ãªã«ã®æ»å ã®ç¬¬3äœã§ããããšææããã
ç±³åœã¯äžäººåœããã®å»è¬åæ¯åºé¡ãäžçäžã§ããããã®ãããäžçã®æ»å ãšããŠã®å»åç ã¯ãææ ®ãã¹ããã®ã§ã¯ãããã3äœããã¯5äœãšããäœãé äœã«ããã
ã¹ã¿ãŒãã£ãŒã«ãã¯ããJournal of the American Medical Associationãèªã«çºè¡šããç»æçãªè«æã§ãäžå¿ èŠãªæè¡ãçŠå¿æ²»çãæè¬ãã¹ãè¬ã®å¯äœçšãªã©ãåå ã§ãã¢ã¡ãªã«ã§ã¯å¹ŽéçŽ22äž5000人ïŒãããã¯28äž4000人ïŒãæ»äº¡ããŠãããšæšå®ããŠããã
2009幎ã«ã¹ã¿ãŒãã£ãŒã«ãæ°ã«ã€ã³ã¿ãã¥ãŒããäœå®¶ã®ãžã§ã³ã»ã©ãããŒãæ°ã¯ãã¢ã¡ãªã«ã«ãããå»çãåå ã®æ»ã«é¢ãã圌女ã®ãé©ãã¹ãã調æ»çµæã宿çã«èªè ã«ç¥ãããŠãããã2015幎ã«ã¯ããïŒã¹ã¿ãŒãã£ãŒã«ãæ°ã®è«æã¯ïŒãã¹ã³ããæ¿åºã®äžæ¢ã§å€§çäžãåŒãèµ·ããããããçç±ããã£ã...ããã¯èµ·ãã£ãããšã§ã¯ãªãããšèгå¯ããŠããã
ãã®ä»£ããã«ã2016幎ãŸã§ãæå³çãªèšæ¶åªå€±ãèµ·ãã£ããã®ã§ãã
ãã®å¹Žããžã§ã³ãºã»ãããã³ã¹å€§åŠã®ããŒãã£ã³ã»ãã«ãªãŒå士ãšãã€ã±ã«ã»ãããšã«å士ã®2人ããBMJïŒæ§è±åœå»åŠéèªïŒã§ãã®è©±é¡ãäžæçã«åŸ©æŽ»ãããå»çãã¹ã«ãããèŽæ»äºè±¡ãããç±³åœã§3çªç®ã«å€§ããªæ»å ããšããŠåã³æããå¹Žéæ»äº¡è æ°ãããã251000人ïŒå šäœã®æ»äº¡è ã®ã»ãŒ10人ã«1人ïŒã§ãããšãã圌ãã®æ°åã«ã€ããŠä¿å®çãªéå°è©äŸ¡ã§ãããšè©äŸ¡ããŠããŸãã
2013幎ã®Journal of Patient Safetyèªã®è«æã§ã¯ãå»çè¡çºã«ãã£ãŠæ¯å¹Ž44äžäººã®ã¢ã¡ãªã«äººãæ»äº¡ããŠãããšå€æãããã®ãããªäžå¹žãªåºæ¥äºãåãå·»ããæ²é»ã®å£ããçµããããããåŒã³ãããŠããŸãã
å šå»çåŠçœ®ã®20ïŒ ãäžèŠãšå®£åããŠæ¥ããªããã«ãªãŒã¯ã2016幎ã«ã¯ã·ã³ãã³ã»ãã¹ãã«ã"人ã ãã±ã¢ãæ±ããŠããç æ°ã§ã¯ãªããåããã±ã¢ã§æ»ã¬ããšã«åž°çµãã "ãšèªã£ãŠããã
ãŸããStarfieldãšMakaryã®äž¡æ°ã¯ã被害è éé£ã«åŒ·ãç°è°ãå±ãã"責ããããã¹ãã¯å人ãããã·ã¹ãã ã§ãã "ãšèª¬æããŠããŸãã
BMJã®èšäºã¯ãWaPoãã¯ãããšããäž»èŠã¡ãã£ã¢ã«äžæçã«å»çã«ããæ»ããããããããã¯ããšããŠçºè¡šããããã®ã®ããã®åé¡ã¯ããã«åã³èŠçãããæ¶ãããæ°å¹ŽåŸã®Makaryã¯ãæå³ã®ããå»çã·ã¹ãã ã®æ¯æ£ãè¡ãããªãããšãåããŠããã
æ°·å±±ã®äžè§ïŒæªãçµæã¯ãã°ãã°éå°è©äŸ¡ããã
çŸä»£å»çãããããå®³ãæšå®ããããšãã人ãã¡ã¯çãéå°å ±åãæ¢åã®ããŒã¿ã»ããã®éçã®ããã«ããã®çŸè±¡ãæ¬åœã«ææ¡ããããšãå°é£ã§ããããããããæ°·å±±ã®äžè§ãããæããã«ã§ããªãããšã«æ³šæãä¿ããŠããã
第äžã®éçã¯ãäž»èŠãªæ»å ãšããŠã®å»åŠãèšç®ããããã«äœ¿ãããã»ãšãã©ã®ããŒã¿ã¯ãå ¥é¢æ£è ããã®ãã®ã§ãããšããããšã§ããã
ããããStarfieldãåŒçšãã2000幎ã®å¥ã®ç ç©¶ã«ããã°ãè¬ç©é¢é£ã®å¯äœçšã¯å€æ¥æ£è ã«ãå€ãããã®ãããªæ£è ã®4%ãã18%ã«åœ±é¿ãåãŒããŠãããšããã
å®éãåœæã®ç ç©¶è ã¯ã倿¥æ£è ã®äžæéã«ãã£ãŠå¹Žé20äžäººè¿ããããã«æ»äº¡ããŠãããšèŠç©ãã£ãŠããã
2ã€ç®ã®æ¬ ç¹ã¯ãæ»äº¡çã«æ³šç®ããããŸããé害ãStarfieldæ°ã®èšèãåããã° "äžå¿«æ "ãšãã£ãéèŽæ»ç転垰ãäžæçã«ãªããã¡ãªç¹ã§ããã
1990幎代åŸåãç ç©¶è ãã¡ã¯ãå»çã®å€±æããäœçŸäžäººãã®å»åž«ã®èšºå¯ãåŠæ¹ãææ¥å€æ¥ã®å蚺ãå ¥é¢ãé·æå ¥é¢ã远å ããäœååãã®è¿œå ã³ã¹ãã«ã€ãªãã£ããšå ±åããŸããã
2018幎ãŸã§ã«ãããå»çå°éå®¶ã¯ã"å»çãã¹ã«ããæ£è ã®éå· "ã®æ°ã¯ã"æ»äº¡çã®40å "ã«ãªããšæšå®ããŠããŸãã
3ã€ç®ã®åé¡ã¯ãç±³åœçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒãæ¯å¹Žæãå€ãæ»å ã®ãªã¹ããäœæããéãæ»äº¡èšºææžã®ããŒã¿ãšæ»äº¡èšºææžã«èšèŒãããŠããåœéçŸç åé¡ïŒICDïŒã³ãŒãã䜿ã£ãŠè¡ã£ãŠããããšã§ãã
ããããStarfieldæ°ãçµè«ä»ããããã«ã"æ»å ãšå€æ¥èšºæãã©ã®ããã«ã³ãŒãåãããŠãããã§ã¯ãç°ææ§ã®å¥åº·åå ãã©ã®çšåºŠäœçšããŠããããçè§£ããããšã¯å®¹æã§ã¯ãªãã"ãšããã
Makaryã¯ãCDCãèŽåœçãªå»çé誀ã®å ±åãæ±ããŠããªãããšãã€ãŸãã"ICDã³ãŒãã«é¢é£ããªãæ»å ãäŸãã°äººçèŠå ãã·ã¹ãã çèŠå ã¯ææ¡ãããŠããªã "ãšææããŠããã
ãããã®èŠå ã«ã¯ããäžååãªæè¡ãæã£ãã¹ã¿ããã倿ãã±ã¢ã®èª€ããã·ã¹ãã ã®æ¬ é¥ãäºé²å¯èœãªå¯äœçšãããã³ã³ãã¥ãŒã¿ãŒã®æ éãè¬ã®éãçš®é¡ã®åãéã...ã蚺æãããªãå€ç§çå䜵çããªã©ã®åé¡ãå«ãŸãããšããã«ãªã£ã¯è¿°ã¹ãŠããŸãã
äžäŸãšããŠãå¡©åãããªãŠã 溶液ã®éå°æäžã§å¹ŒãåäŸã亡ãããå®¶æã¯ãå€ãã®å·ã§ç é¢ã®ç¹æ»Žè¬ã調åããè¬å€åž«ã«ãäœã®èŠä»¶ããèœåã®èšŒæããªããããšãç¥ããŸããã
第åã®èª²é¡ã¯ãå®çŸ©ãšåé¡ã®é£ããã§ãããäŸãã°ãå»çãã¹ã¯äžäœçºã®ãšã©ãŒãªã®ããå®è¡ã®ãšã©ãŒãªã®ããèšç»ã®ãšã©ãŒãªã®ãã
çšéäŸåçãªè¬ç©æå®³åå¿ã«ã€ããŠã¯ã©ãã§ãããããåå¿ã¯äºæž¬å¯èœãªãã®ãïŒããªãã¡ãæ¯æ§ãå¯äœçšãè¬ç©çžäºäœçšã«é¢ããæ¢ç¥ã®äºå®ã«åºã¥ããã®ãïŒããããšãäºæž¬äžå¯èœãªãã®ãïŒäŸãã°ãã¢ã¬ã«ã®ãŒãäžèæ§ããç¹ç°äœè³ªããªã©ã®èŠå ããçãããã®ãïŒã
è¬ç©ã®èª€æäžïŒèª€æäžãäžæ¯ãæ²»ç倱æãªã©ïŒã«å ããèšºææ¹æ³ïŒæ©æ¢°çããã³æŸå°ç·çïŒãæè¡ããã®ä»ã®äŸµè¥²çåŠçœ®ãå ¥é¢ãå®å šã§ãªãæ³šå°æ¹æ³ãå®å šã§ãªã茞è¡ããæ²»çããå»åž«èªèº«ããªã©ããç°ææ§å¹æãåŒãèµ·ããå¯èœæ§ããããŸãã
äŸãã°ãå€§è žå èŠé¡æ€æ»ã§ã¯ãç©¿åãææãåºè¡ãªã©ã®é倧ãªãªã¹ã¯ãããããšãç ç©¶ã§æããã«ãããŠãããããããå蚺è ã®4ïŒ ãæ€æ»åŸ1ã¶æä»¥å ã«å ¥é¢ããã»ã©æ·±å»ãªå䜵çãçµéšããŠããŸãã
COVIDæä»£ã®æ»å ã©ã³ãã³ã°
ãã«ãªãŒã¯ããç§ãã¡ã¯çãïŒå»çé誀ãïŒããã«ããããããšããç¥ã£ãŠããŸããããç§ãã¡ã¯ãŸãããããããã«é »ç¹ã«å ¬ç¶ãšè°è«ãããªãããç¥ã£ãŠããŸãããšãç°ææ§ïŒiatrogenesisïŒã®ã¿ããŒæ§ãææããã
äžæ¹ãCDCã¯æ»å ã©ã³ãã³ã°ã«ã€ããŠãã©ã®æ»å ã "ã©ã³ãã³ã°ã®å¯Ÿè±¡ "ã«ãªããã«ã€ããŠã®CDCå éšã®æ±ºå®ããçãã "ããçšåºŠæ£æçãªæç¶ã "ã§ããããšãççŽã«è¿°ã¹ãŠããã
ãŸãããã®ã©ã³ãã³ã°ã¯ãå¿ ãããå ¬è¡è¡çäžæãéèŠãªæ»å ã瀺ããŠããããã§ã¯ãªããããšãèªããŠããã
COVID-19é¢é£ã®å»ç察çãå¥åº·æ¿çã®ç»å Žã«ãããã¿ããŒãæã¡ç Žããå ¬è¡è¡çäžéèŠãªå»ç殺人ãã·ãŒã³ã«ãã£ãšã¹ãããã©ã€ããåœãŠãããšãæ¥åãšãªã£ãŠããã®ã ã
ããšãã°ã2020幎ã«å ±åãããå¹³å寿åœã®2幎éã®åçãªäœäžãšãæäžäœã®ãã¥ãŒãšãŒã¯å·ã®3幎éã®äœäž-æŒ ç¶ãšããã³ãããã¯ããšè¬ç©ã®éå°æåã®ããã«ããŠããã-ã¯ãã¬ã ãã·ãã«ãªã©ã®èŽæ»çã®é«ãè¬ã匷調ãããæ¿åºã®ã€ã³ã»ã³ãã£ãã«ããåé¯ããCOVID-19æ²»çæé ã®æŒãä»ããšé¢ä¿ãããã®ã ãããã
2021幎以éã«èгå¯ãããå šæ»å æ»äº¡çã®æ¥äžæã¯ãç±³åœé£åå»è¬åå±ãèŽåœçãªCOVID-19ã¯ã¯ãã³ãèš±å¯ããããšãšé¢ä¿ãããã®ã§ããããïŒ
COVID-19ã¯ã¯ãã³ã®å±éºæ§ã«ã€ããŠç¥ãããŠããããšããããŠç§ãã¡ãåŠã³ç¶ããŠããããšãèãããšãCDCã®çŸåšã®çŸç ã©ã³ãã³ã°ïŒ5倧æ»å ãšããŠå¿èç ããããCOVID-19ãäºæ ãè³åäžãæããŠããïŒã¯ãç¶¿å¯ã«ç²Ÿæ»ããå¿ èŠããããŸãã
ãã®5ã€ã®æ»å ã«ã¯ç¢ºãã«è€æ°ã®å±éºå åã絡ãã§ããããCOVID-19ã®æ¥çš®ããããã®åéã®æ»è ãé害è ã®æ°ãå¢ãããŠããããšã¯ç¢ºãã§ããã
ã¯ã¯ãã³æ¥çš®åŸãå¿èã«èŽåœçãªé害ãçºçãããšã®å ±åãåºãŸã£ãã
ç°åžžã«å€§ããæ»æçãªãã¿ãŒããçã®çºçããç¹ã«è¥ãæ£è ã§å¢å ãããšããç çåŠè ã®å ±åã
COVID-19ã®æ¥çš®è ãæ»äº¡ãããªã¹ã¯ãé«ãããšã瀺ãäžçåå°ã®ããŒã¿ã
COVID-19ã¯ã¯ãã³ã®å±éãšåæã«æ¥å¢ããèªåè»äºæ -ãã¥ãŒã¹ã§ã¯ãäºæ ãšçºäœãè¬ã®ãå»çãšããœãŒãããªã©æ¢ç¥ã®æå®³äºè±¡ãçµã³ã€ããŠå ±éããŠããŸãã
COVID-19ã¯ã¯ãã³æ¥çš®åŸã®æ§ã ãªã¿ã€ãã®è³åäžã説æããç ç©¶çºè¡šã
CDCã®æ»å ã®ãããã10ãã«ãå ¥ã£ãŠããè èé害ãšãã¬ã ãã·ãã«ãCOVID-19ã®äºé²æ¥çš®ãšã®é¢é£æ§ãç ç©¶ãããŠããŸãã
Children's Health Defenseãå§èšããZogbyã®2ã€ã®äžè«èª¿æ»ã§ã¯ãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããåçè ã®15ïŒ ã22ïŒ ããæ°é±éããæ°ã¶æã®ãã¡ã«ãæ°ããç ç¶ãšèšºæããããšå ±åããŠããŸãã
æåã®äžè«èª¿æ»ã§ã¯ãåçè ãæããäžäœ5ã€ã®ç ç¶ã¯ãè¡æ ãå¿èçºäœãèé害ãèãŸãã¯èºã®è¡æ ãè³åäžã§ããã
2åç®ã®æç¥šã§ã¯ãåããã®ã«å ããŠãèªå·±å ç«çŸæ£ãæçµåšæã®ä¹±ããã®ã©ã³ã»ãã¬ãŒçå矀ããã«éº»çºãäžäœã«æããããŠããŸãã
ãŸãã26%ãã30%ã®äººããCOVID-19ã¯ã¯ãã³æ¥çš®åŸã«å»ç蚺æãåãã人ãç¥ã£ãŠãããšåçããŠããŸãã
ãšã©ãŒã§ã¯ãªã
殺å·ãããã³ãŒã«ãäžæ£ãžã£ãã«ããè¢«å®³ãæ¡å€§ããäžããã¯ããå»çé誀ããšããç¡å®³ãããªèšèã§å»åç ãé ãããšã¯äžå¯èœã§ãããæå³çãªè¢«å®³ãããã«ã¯å€§é殺æ®ãèªã£ãŠããããšããŸããŸãæçœã«ãªã£ãŠããŠããã
ã€ãªããã«ãšã£ãŠããã®ãäžåãªããå¥åº·ãç Žå£ãããå»çææã«å¯Ÿããææžçã¯ãèªå·±äœ¿çšãç®çãšããããåçŽãªä»å ¥ãããªãã¡ã害ãããå¹ããªããããšãå®èšŒãããä»å ¥ã«ç«ã¡æ»ããå°éå®¶ã®ä»å ¥ããæå°éã«ãŸã§ãæžããããšã§ãã£ãã
圌ã®èãã§ã¯ãä»£æ¿æ¡ã¯ãæœåšçã«èŽåœçãŸãã¯ç¡å¹ãªçµæã䌎ãããèšç»ãããèšèšãããå°çããé»èªãç¶ããããšã§ãã£ãã